Pcn86 - Validation of the Impact of Treatment Evolution in Non-Small Cell Lung Cancer (Nsclc) Model (Iten): A Discrete Event Patient Simulation

Value in Health- United Kingdom

doi 10.1016/j.jval.2018.09.168

Full Text

Abstract

Available in

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

MA18.02 the Impact of Treatment Evolution in NSCLC (iTEN) Model: Development and Validation

Journal of Thoracic Oncology

Respiratory Medicine

English

PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Value in Health

Occupational Health

English

P2.15-09 the Impact of Treatment Evolution in NSCLC (iTEN) Model: Survival and Cost of Treating Patients With Advanced NSCLC in 2017

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.17-11 Pattern and Survival Impact of Neoadjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) in a Prospective Lung Resection Cohort

Journal of Thoracic Oncology

Respiratory Medicine

English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine

German

Tumor Evolution in Non-Small-Cell Lung Cancer

Cancer Research

German

P3.15-12 Survival Impact of Patient Enrollment in Antineoplastic Drug Trials for Stage IV Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-129 Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

Journal of Thoracic Oncology

Respiratory Medicine

English

Patient Preferences for Chemotherapy in the Treatment of Non-Small Cell Lung Cancer: A Multicenter Discrete Choice Experiment (DCE) Study in China

Patient Preference and Adherence

Social Sciences

English